Cancer is so limited
It cannot cripple love
It cannot shatter hope
It cannot corrode faith
It cannot destroy peace
It cannot kill freindship
It cannot suppress memories
It cannot silience courage
It cannot invade the soul
It cannot steal eternal life
It cannot conquer the spirt
Cancer I did not give you the right. To invade my body and take a bite. This is my Body and with all my might . I will prevail with one hell of a fight. To the cancer inside, I will battle and kill. For that is my bodies God given will. To my cancer, these words I do send. Your life is short and near the end.
Born In The USA
One Of My Favorite Tunes
Hello my friend we meet again It's been a while where should we begin ... feels like forever....... Within my heart are memories of perfect love that you gave to me OH, I remember
Chorus: When you are with me I'm free...I'm careless...I believe Above all the others we'll fly This brings tears to my eyes
We've seen our share of up's and down's Oh, how quickly life can turn around ... in an instantIt feels so good to reunite within yourself and within your mind Let's find peace there When you are with me I'm free...I'm careless...I believe Above all the others we'll fly This brings tears to my eyes My Sacrifice
I just want to say hello again I just want to say hello again When you are with me I'm free...I'm careless...I believe Above all the others we'll fly This brings tears to my eyes When you are with meI'm free...I'm careless...I believeAbove all the others we'll fly This brings tears to my eyes When you are with me
I just want to say hello againI just want to say hello again
New Cancer Fighting Drug Begins Phase I Testing: May Provide Patients with Chemotherapy Alternative
A new clinical trial is underway to study a cancer drug known as EP-100 in patients with skin, ovarian, breast, prostate, endometrial and pancreatic cancer.
The Phase 1 trial will study 36 adult patients who have had biopsies that demonstrate high levels of the luteinizing releasing hormone receptors (LHRH), a prominent characteristic of cancer cells. Scientists will give patients a specific amount of EP-100 through an intravenous method for three out of the four week study.
The goal of EP-100 is to be a membrane disrupting peptide (tMDP) that goes after specific cancer cells in patients with solid tumors. Researchers are testing the drug to perform a routine they call “seek and destroy,” which will go after cells in one’s body that may have increased amounts of LHRH.
Preliminary results from the pre-clinical trials held in ovarian cancer cell lines were presented at the American Association for Cancer Research (AACR) annual meeting, located in Denver, CO. Physicians and researchers are hopeful that the drug will be a huge advancement for uterine and ovarian cancer patients. Many patients with advanced cancer will require new treatments and EP-100 may be the next paradigm of research.
Studies with mice have shown a decrease in size of tumors in people with several different types of cancer. Researchers are hopeful that EP-100 will be effective for patients and become a solidified alternative to chemotherapy and radiation with less negative results. The most uplifting news yet show that this drug does not harm normal, healthy cells, which may lead to higher standards to existing cancer therapies.
By providing FDA alerts, drug information, drug interactions and the latest news about prescription, over the counter medications and clinical trials, we can ensure an environment where patients have the best knowledge on their medical treatment and health.